SCHEDULE: Whetstone Capital Discloses 5.4% Stake in Health Catalyst

Whetstone Capital Advisors and David Atterbury have reported a 5.4% beneficial ownership stake in Health Catalyst, Inc. as of June 30, 2025.

Summary

• Whetstone Capital Advisors, LLC and Mr. David Atterbury (collectively, the "Reporting Persons") have filed a Schedule 13G.
• The filing indicates beneficial ownership of 3,731,350 shares of Health Catalyst, Inc. Common Stock.
• This ownership represents 5.4% of the class of securities.
• The Reporting Persons hold shared voting power and shared dispositive power over all 3,731,350 shares.
• Whetstone Capital Advisors, LLC is classified as an Investment Adviser, and Mr. David Atterbury is classified as a Control Person and Individual.
• The securities were not acquired for the purpose of changing or influencing the control of the issuer.

Sentiment

Score: 5

Explanation: The filing is a factual disclosure of beneficial ownership and does not contain qualitative information to assess sentiment beyond the neutral act of reporting a stake. The acquisition of a 5.4% stake by an investment advisor could be viewed as a positive signal of institutional interest.

Future Outlook

NA

Industry Context

This filing indicates an institutional investor, Whetstone Capital Advisors, has taken a significant passive stake in Health Catalyst, a company operating in the healthcare technology sector. Such disclosures can signal investor confidence or strategic interest in the company's market position or future prospects within the industry.

Stakeholder Impact

• Shareholders: The disclosure of a new significant institutional investor may positively influence market perception and potentially the stock price, signaling confidence in the company.

Key Dates

Keywords

Health Catalyst, Whetstone Capital Advisors, David Atterbury, Schedule 13G, beneficial ownership, common stock, healthcare technology, investment advisor